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ABSTRACT
Dlx homeobox genes are first expressed in embry-
onic retina at E11.5. The Dlx1/Dlx2 null retina has a
reduced ganglion cell layer (GCL), with loss of late-
born differentiated retinal ganglion cells (RGCs) due
to increased apoptosis. TrkB signaling is proposed
to regulate the dynamics of RGC apoptosis through-
out development. DLX2 expression markedly pre-
cedes the onset of TrkB expression in the GCL; TrkB
co-expression with Dlx2 and RGC markers is well-
established by E13.5. In the Dlx1/Dlx2 null retina,
TrkB expression is significantly reduced by E16.5.
We demonstrated that DLX2 binds to a specific
region of the TrkB promoter in retinal neuroepithe-
lium during embryogenesis. In vitro confirmation
and the functional consequences of DLX2 binding to
this TrkB regulatory region support TrkB as a Dlx2
transcriptional target. Furthermore, ectopic Dlx2
expression in retinal explants activates TrkB expres-
sion and Dlx2 knockdown in primary retinal cultures
results in reduced TrkB expression. RGC differentia-
tion and survival require the coordinated expression
of transcription factors. This study establishes a
direct transcriptional relationship between a home-
odomain protein involved in RGC differentiation and
a neurotrophin receptor implicated in RGC survival.
Signaling mediated by TrkB may contribute to
survival of late-born RGCs whose terminal differ-
entiation is regulated by Dlx gene function.
INTRODUCTION
During vertebrate retinogenesis several distinct cell types
are generated from retinal progenitors (1). In the mouse,
retinal ganglion cells (RGCs) are generated ﬁrst followed
by cones, horizontal cells, amacrine cells, rods, bipolar
cells and Mu ¨ ller glia (2–4). In the murine retina, RGCs are
born between embryonic day (E) 10 and postnatal day (P)
2 with a maximal birth rate at E15. Cell death occurs
during RGC genesis in two distinct phases (5). The ﬁrst
phase occurs at E15.5 and corresponds with the peak of
RGC neurogenesis (6). The second occurs after birth,
peaking at P2 and correlates with the elaboration of RGC
projections to the superior colliculus (SC) (7).
The vertebrate Distal-less (Dlx) homeobox gene family
consists of six murine members (8) organized into three
bigenic gene clusters (9–11). Four Dlx family members
have been implicated in neurogenesis in the mouse: Dlx1,
Dlx2, Dlx5 and Dlx6 (12–14) with Dlx1 and Dlx2 further
implicated in retinogenesis (15–17). Previous work estab-
lished that Dlx1 and Dlx2 are both expressed in the retinal
neuroepithelium by E12.5 (15). Expression of Dlx1
becomes largely restricted to the ganglion cell layer
(GCL); perinatally, its expression is down-regulated.
Dlx2 is expressed throughout the lifetime of the mouse
with expression becoming restricted to RGCs, amacrine
and horizontal cells (16). Characterization of the Dlx1/
Dlx2 null mouse demonstrated loss of approximately one-
third of RGCs at E18.5 (17). Dlx1/Dlx2 mutant retinas
contain disproportionately higher numbers of RGCs born
prior to E13.5 and a decreased population of later born
RGCs, with loss of RGCs due to increased apoptosis
between E13.5 and E18.5 (17). RGC numbers in the adult
Dlx1/Dlx2 mutant retina cannot be determined as mutants
die perinatally. The molecular mechanisms underlying
RGC apoptosis in the Dlx1/Dlx2 double knockout retina
have not been established.
TrkB, a member of the neurotrophin receptor family
encoded by the NTRK2 gene, demonstrates speciﬁc
binding aﬃnity for brain derived neurotrophic factor
(BDNF) and neurotrophin NT4/5 (18–20). Target-derived
BDNF signaling via TrkB modulates cell death during
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domain of the TrkBFL receptor results in a dose-dependent
increase in the peak RGC death rate, although ﬁnal RGC
numbers remain normal (22).
To investigate the role of Dlx genes in the processes
of RGC diﬀerentiation and survival, we have tested
the hypothesis that DLX2 regulates TrkB expression
during retinal development. We show that DLX2 expres-
sion precedes TrkB in the embryonic GCL by 1–2 days
with DLX2 expressing retinal neuroepithelial cells
co-expressing TrkB upon migration to the inner retina.
As well, DLX2 directly binds to a speciﬁc TrkB proximal
promoter region in vivo, and functions as a transcriptional
activator of TrkB expression in vitro. We also demonstrate
that loss or gain of Dlx2 function results in a correspond-
ing decrease or increase of TrkB expression within the
developing retina.
MATERIALS AND METHODS
Animal and tissuepreparation
Wild-type tissues were obtained from the CD-1 (ICR) BR
Swiss strain of albino mice (Charles River Laboratories,
Worcester, MA, USA). Dlx1/Dlx2 knockout mice were
generated as previously described (13,23). Embryonic age
was determined by the day of appearance of the vaginal
plug (E0.5) and conﬁrmed by morphological criteria.
For immunostaining studies, E16.5 and E18.5 eyes were
dissected from embryos while E13.5 eyes were left in situ.
Tissues were processed as previously described (16). All
animal protocols were conducted in accordance with
guidelines set by the Canadian Council on Animal Care
and the University of Manitoba animal care committee.
Dlx1/Dlx2 null mice were genotyped as described (24).
For comparative studies, all Dlx1/Dlx2 mutants were
paired with wild-type littermate controls.
Immunohistochemistry andimmunofluorescence
Immunohistochemistry and immunoﬂuorescence staining
on cryosections were performed as described (16). Primary
antibodies used were: rabbit anti-BRN3b (1:200, Babco,
Richmond, CA, USA), goat anti-BRN3b (1:200, Santa
Cruz, Santa Cruz, CA, USA), mouse anti-Chat (1:100,
Chemicon, Temacula, CA, USA), rabbit anti-CHX10
(1:700, courtesy Dr T. Jessell, Columbia University),
rabbit anti-DLX2 (1:250), mouse anti-ISLET-1 (1:600,
Developmental Studies Hybridoma Bank, University of
Iowa, IA, USA), mouse anti-NF165 (1:50, Developmental
Studies Hybridoma Bank, University of Iowa, IA, USA),
rabbit anti-PROX1 (1:500, courtesy Dr M. Nakafuku,
University of Tokyo), mouse anti-Rho4D2 (1:80, courtesy
Dr R. Molday, University of British Columbia), mouse
anti-Syntaxin (1:6000, Sigma, St Louis, MO, USA), rabbit
anti-TrkB (1:200, Santa Cruz). Peanut Agglutinin (PNA)
(1:2000, Vector Laboratories, Burlingame, CA, USA)
staining was also used for detection of cone photorecep-
tors. Secondary antibodies and ﬂuorescent tertiary mole-
cules used were FITC-conjugated goat anti-rabbit (1:100,
Sigma), Texas red-conjugated donkey anti-rabbit (1:200,
Jackson Immunoresearch, West Grove, PA, USA),
Texas red-conjugated donkey anti-mouse (1:200, Jackson
Immuno-research),Texasred-conjugateddonkeyanti-goat
(1:200, Jackson Immunoresearch). Peanut agglutinin was
visualized using streptavidin-conjugated Texas Red
(1:200, Vector Laboratories). Negative controls omitted
the primary antibody.
Chromatin immunoprecipitation (ChIP) assays
ChIP assays were performed as described previously using
E16.5 retinal tissues (25). Oligonucleotide primers were
designed according to distinct regions of the TrkB gene
sequence (Ensemble Gene ID: ENSMUSG0000055254).
Region 1 (R1-pro) was located within the 50 proximal
promoter 842bp upstream of the transcription start site.
For R1-pro, the sense primer was 50-CAGAGAGCATC
TCTGAGAG-30 and the anti-sense primer was 50-GCA
CTGCCTTTCTGA-CTGG-30. Six other regions of the
proximal TrkB promoter were also assessed (refer to
Supplementary Figure 4 and legend for oligonucleotide
primer sequences). Polymerase chain reaction (PCR) was
performed on genomic DNA derived from E16.5 mouse
embryos as a positive control. PCR products were
separated by gel electrophoresis, puriﬁed and then ligated
into the pCR2.1 TOPO vector using a TOPO TA cloning
kit (Invitrogen, Burlington, ON, USA). Recombinant
plasmid DNA was extracted using a MiniPrep Kit (Qiagen
Inc., Mississauga, ON, USA) and M13 reverse universal
primer was used for conﬁrmation of sequence.
Nuclear extracts and gel shiftassays
Liver or retina tissues were obtained from wild-type CD1
mice at E13.5 and triturated in 1  PBS to obtain single
cell suspensions. Following centrifugation at 200r.p.m.,
1ml of Buﬀer A (20mM HEPES/KOH pH 7.5, 10mM
KCl, 1.5mM MgCl2, 1mM EDTA, 1mM EGTA, 1mM
DTT, 250mM sucrose) was added to the pellet, placed on
ice (15min) and the suspension was then passed 40 times
through a 26G 0.500 needle and spun at 4500r.p.m.
(10min.). The pellet was then washed with Buﬀer A and
10ml of 10% NP-40 was added, rotated at 48C (10min.),
spun at 13000r.p.m. (15min.) and then 200ml of Nuclear
Extraction Buﬀer (20mM HEPES/KOH pH 7.9, 420mM
NaCl, 1.5mM MgCl2, 0.2mM EDTA, 0.5mM DTT, 25%
glycerol) was added to the pellet, rotated at 48C (30min.),
spun at 13000r.p.m. (15min.) and the resultant super-
natant was used as nuclear extract.
Electrophoretic mobility gel shift assays (EMSA) were
performed as reported previously (25). The TrkB promo-
ter region was digested with EcoRI, then the 50 overhang
was ﬁlled in with the large fragment of DNA polymerase I
(Klenow) in the presence of radiolabeled (a
32P) dATP.
Recombinant protein of 100ng or 1mg of nuclear extract
was used per reaction. For ‘cold competition’ assays,
double-stranded unlabeled fragments were added at 100-
fold excess. For ‘supershift’ assays, speciﬁc polyclonal
DLX2 antibodies were used; a rabbit polyclonal antibody
to mouse immunoglobulin G (Jackson Immunoresearch)
was utilized as an antibody control. Sequences of the two
putative TAAT/ATTA homeodomain binding motifs
from the TrkB promoter region were used to generate
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Double-stranded oligonucleotides were incubated with the
T4 polynucleotide kinase (T4 PNK) and a
32P-ATP.
Nuclear extracts were incubated with 1  binding buﬀer,
poly(dI-dC), 1mM PMSF and P
32-labeled DNA probes.
For ‘cold competition’ assays, unlabeled double-stranded
oligonucleotides were added at 100-fold excess. Reactions
were resolved on a 4% non-denaturing polyacrylamide
(37.5: 1 acrylamide/bisacrylamide) gel in 0.5  Tris–
Borate–EDTA solution. Gels were exposed to ﬁlm and
autoradiography was performed overnight at  708C.
Motif P-TrkB1: sense primer: 50-CCAGCATTCATTAG
ACTCTTCCTGTC-30, antisense primer: 50-GACAGG
AAGAGTCTAATGAATGCTGG-30; motif PM-TrkB1
(mutant): sense primer: 50-CCAGCATTCAGGAGAC
TCTTCCTGTC-30, antisense primer: 50 GACAGGAAG
AGTCTCCTGAATGCTGG-30; motif P-TrkB2: sense
primer: 50-GGAGTGGGGCAGTAATTACTCCTCCCT
TCC-30, antisense primer: 50- GGAAGGGAGGAGTA
ATTACTGCCCCACTCC-30; motif PM-TrkB2 (mutant):
sense primer: 50- GGAGTGGGGCAGTAGTTACTCCT
CCCTTCC-30, antisense primer: 50-GGAAGGGAGGAG
TAACTACTGCCCCACTCC-30.
Reporter assays
Eﬀector plasmids expressing Dlx2 under the control of
a CMV promoter were constructed by insertion of a PCR
ampliﬁed 1020bp Dlx2 cDNA (courtesy Dr John
Rubenstein, University of California, San Francisco)
into the pcDNA3 vector (Invitrogen). Reporter plasmids
were constructed by inserting a 274bp R1-pro fragment
from position 57, 445, 126–57, 445, 399, chromosome 13,
TrkB 50 upstream region (Ensembl, ENSMUSG000
00055254) into the pGL3 basic promoter vector
(Promega, Madison, WI, USA).
Transientco-transfectionexperimentswereperformedin
the HEK293 human embryonic kidney cell line (ATCC,
Manassas, VA, USA). HEK293 cells were grown and
maintained in alpha Dulbecco’s modiﬁed Eagle’s medium
(aDMEM) supplemented with 7.5% fetal bovine serum,
2.5% calf serum and 1% penicillin–streptomycin at 378C
with 5% CO2. Cells were seeded 24h before transfection at
a density of 1 10
7/36mm
2 dish. Cells were transiently
transfected using Lipofectamine 2000 reagent (Invitrogen).
All transfections contained pRSV-b-gal (Promega) as a
control for transfection eﬃciency. Luciferase activity was
measured using the Luciferase Reporter Assay System
(Promega) and a standard luminometer (Molecular
Devices, Sunnyvale, CA, USA).
Retinalexplants and retroviral transduction
Replication-incompetent ecotropic pMXIE retroviruses
encoding murine Dlx2 (pMXIE-EGFP/dlx2)o rDlx1
(pMXIE-EGFP/dlx1) were obtained by inserting 999bp
Dlx2 or 768bp Dlx1 cDNA (courtesy Dr John Rubenstein)
into the pMXIE-EGFP retroviral vector (courtesy
Dr D. Van der Kooy, University of Toronto, 26). Eyes
were dissected from embryos in sterile 1  PBS and
transferred to dishes containing DMEM/F12 media
(Gibco/Invitrogen). Retinas were dissected under sterile
conditions from eyes with the lens and iris intact and
transferred onto Millicell-CM 0.4mM ﬁlters (Millipore)
with the lens facing away from the membrane. Filters
were transferred to 6-well culture plates containing media
enriched with 1 N2 supplement, 1 MEM sodium
pyruvate, 2mM L-glutamine (all Gibco/Invitrogen),
5mg/ml Insulin (Sigma), 1U/ml penicillin/1mg/ml strep-
tomycin (Sigma), 1:10 dilution of retroviral solution
(500000PFU/ml pMXIE-EGFP, 750000PFU/ml
pMXIE-EGFP/dlx1, 750000PFU/ml pMXIE-EGFP/
dlx2) and 0.1mg/ml of polybrene (Sigma). Media was
exchanged every 2 days. Retrovirus and polybrene were
included only in the initial culture media. Explants were
cultured at 378C with 5% CO2 in a humidiﬁed incubator
for 10 days.
Primary retinal cell culture
E18.5 CD-1 mice retinas were dissociated and collected in
Hank’s Balanced Salt Solution (HBSS) and incubated for
10min at room temperature with 0.05mg/ml trypsin
(Gibco). Soybean trypsin inhibitor (Sigma) was added to
the ﬁnal concentration of 2mg/ml. The cells were then
pelleted by centrifugation (1200r.p.m., 5min), resus-
pended and gently triturated to single-cell suspension in
HBSS containing 100mg/ml DNase I (Sigma). The cell
suspension was transferred to a tube containing
Neurobasal medium with B-27 supplement (Gibco) and
1  antimycotic antibiotic. Cells were counted and 3 10
5
cells were plated per well (poly-D-lysine- coated 12-well
plate) and cultured at 378C with 5% CO2.
Transfection ofprimary retinacells with siRNA
Two duplex siRNAs were designed to target mouse Dlx2
coding sequence and a control siRNA was synthesized to
scrambled Dlx2 coding sequence (Invitrogen) as follows:
mDlx2-R1-sense: 50-(Fluo)GGAAGACCUUGAGCCUG
AAdTdT, mDlx2-R1-antisense: 50-UUCAGGCUCAAG
GUCUUCCdTdT; mDlx2-R2-sense: 50-(Fluo) UCUGGU
UCCAGAACCGCCGdTdT-30,m Dlx2-R2-antisense:
50-CGGCGGUUCUGGAACCAGAdTdT-30; control
sense: 50-(Fluo) UUCUCCGAACGUGUCACGUdTdT-30,
control antisense: 50-ACGUGACACGUUCGGAGAAd
TdT-30. Transient transfection using Lipofectamine 2000
(Invitrogen) was carried out on the second day of tissue
culture. siRNA to a ﬁnal concentration of 40 nM (following
Qiagen RNAifect transfection handbook protocol) was used.
Cells were washed with cold PBS and lysed in RNA-bee (Tel-
Test, Inc.); triplicate lysates were pooled and total RNA was
puriﬁed according to the manufacturer’s protocol 48h after
transfection.
Reverse transcriptionPCR
For reverse transcription (RT) PCR experiments, 1mgo f
total RNA was used as a template to synthesize ﬁrst-
strand cDNA. Prior to the RT step, RNA samples were
treated with DNase I (Sigma) for 15min at room
temperature to digest the genomic DNA; stop solution
was added and samples were incubated at 708C for 10min
to inactivate the DNase I, and then put immediately on
ice. The total RT reaction volume was 20ml and the
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TM cDNA synthesis kit (Bio-Rad) was used with the
following conditions: 5min at 258C, 30min at 428C and
5min at 858C. The cDNA served as a template for Dlx2,
TrkB and GAPDH ampliﬁcation. A 50ml PCR reactions
were performed, containing: 5ml1 0   PCR buﬀer, 3ml
MgCl2 (25mM), 1ml dNTP (10mM each), 1ml each
primer (10mM), 2ml cDNA, 10ml5   Qbuﬀer and 3 U
HotStar Taq DNA Polymerase (Qiagen). PCR ampliﬁca-
tion conditions were: 948C, 15min for one cycle; 94C,
30s, 578C, 30s, and 72C, 1min for 39 cycles and an
extension cycle at 728C for 10min. The PCR products
were run on a 1.5% agarose gel with ethidium bromide.
For RT-PCR, the oligonucleotide primers used were:
Dlx2-F(p6): ccaaactcaggtcaaaatctg, Dlx2-R(p2): tta-
gaaaatcgtccccgcg; mTrkB-F1: accttgacttgtctgacctgat,
mTrkB-R1: cttctcctacaaggttttctgc; GAPDH-F: ctcatgac-
cacagtccatgc, GAPDH-R: cacattggggggtaggaacac.
Cell countingand statistical analysis
For quantiﬁcation of TrkB expression, paired Dlx1/Dlx2
mutant and wild-type retinas were taken at regularly
spaced intervals in order to completely survey each retina.
Five sets of eyes consisting of one Dlx1/Dlx2 homozygous
mutant and one wild-type eye from littermate pairs were
used for quantiﬁcation at E13.5, E16.5 and E18.5. Eyes
were sectioned at 12mM. Sections through the widest
region of the optic nerve head were used as a centered start
point and were matched histologically. The start section
and sections 120 and 240mM above and below were used
for immunostaining. For E13.5 and E16.5 sections 60 and
120mM above and below the start section were used due to
smaller eye size. Sections were ﬂuorescently labeled for
TrkB expression. Counts and statistical analysis was
performed as previously described (17).
For retroviral transduction studies, pairs of sections
from each explant were immunoassayed with cell-type
speciﬁc markers. Sections were then imaged by confocal
laser microscopy. Green ﬂuorescent cells were counted
to represent the total number of transduced cells.
Cells with both green and red ﬂuorescence were then
counted to identify transduced cells expressing a parti-
cular marker. The proportion of transduced cells expres-
sing a speciﬁc marker was then determined. Mean counts
from paired tissues provided a representative proportion
of labeled cells for the explants. The Student’s t-test was
utilized to make comparisons between proportions of
marker expression among cells transduced by pMXIE
empty vectors, pMXIE/dlx1 vectors and pMXIE/dlx2
vectors.
Microscopy and imaging
Fluorescent images were acquired using an Olympus IX81
inverted microscope equipped with a Fluoview FV500
confocal laser scanning system (Olympus Optical Co.,
Tokyo, Japan). An Olympus BX51 microscope equipped
with a SPOT 1.3.0 digital camera (Diagnostic Instruments
Inc., Sterling Heights, MI, USA) was used for non-
ﬂuorescent image capture. Images were processed using
Adobe Photoshop 5.5 (Adobe Systems, Mountain View,
CA, USA) and were formatted, resized and rotated for the
purposes of presentation.
RESULTS
TrkB isexpressed from E12.5and is restricted to
RGCs andamacrine cellsin the murineretina
In order to deﬁne temporal and spatial localization of
TrkB expression in the developing mouse retina, we used a
well-characterized antibody to TrkB (27–30) for immuno-
histochemistry. Onset of TrkB expression occurred at
E12.5 (Figure 1A) with expression occurring in migrating
cells in the central retinal neuroepithelium, the anatomic
region from which the ganglion cell layer (GCL)
originates. Some non-speciﬁc staining is evident adjacent
to ventricles, along epithelial edges and in the peripheral
region of the retina. This is an artefact of the immuno-
histochemical staining procedure, when the antibody has
minimal epitope to bind (data not shown). At E13.5 there
is extensive expression of TrkB in the vitreal (inner) region
of the central retina (Figure 1B). TrkB expression in the
inner retina continues throughout embryonic development
(Figure 1C and D) with expression restricted to the
recently established GCL. By P14 lamination of the
murine retina is established (Figure 1E). TrkB expression
is found in the GCL (Figure 1E, arrows) without
expression identiﬁed in the inner nuclear layer (INL) or
outer nuclear layer (ONL). In the adult retina, expression
of TrkB remains primarily restricted to the GCL
(Figure 1F, arrows). However, expression of TrkB can
now be identiﬁed in the INL (Figure 1F, asterisk) and in
the corresponding inner plexiform layer (IPL). Expression
of many amacrine cell subtype markers occurs very late in
retinogenesis; a good example is tyrosine hydroxylase (16).
The onset of Trkb expression in amacrine cells is after P14
(also refer to Supplementary Figure 3C).
Immunoﬂuorescent co-localization studies with cell-
type-speciﬁc antibodies to retinal ganglion, amacrine,
horizontal, bipolar cells and cone and rod photoreceptors
were performed to conﬁrm the classes of cells expressing
TrkB (Supplementary Figure 1–3). When evaluating these
experiments, it is important to note that up to 50% of cells
in the GCL are displaced amacrine cells in adult murine
retinas (16). Co-expression with Brn3b and Islet1 tran-
scription factors, markers expressed in RGCs (31–33)
conﬁrmed that TrkB expressing cells in the GCL were
indeed RGCs (Supplementary Figures 1 and 2).
Co-localization of TrkB with Islet1 and Brn3B was
detected at E13.5 indicating that the onset of TrkB
expression begins soon after establishment of RGC
diﬀerentiation (Supplementary Figure 1C, Islet1;
Supplementary Figure 2C, Brn3B). Co-localization with
syntaxin, a marker of amacrine cells (34) was identiﬁed in
the IPL and in a subpopulation of cells in the INL of the
adult retina (Supplementary Figure 3C). Interestingly,
there was no co-expression with choline acetyl-transferase
(ChAT), a marker of cholinergic amacrine cells (35)
(Supplementary Figure 3F) indicating that only a subset
of amacrine cells express TrkB. Co-expression could not
be detected with markers of horizontal (Prox1, 36)
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with markers of rod (Rho4D2, 38) or cone photoreceptors
(PNA, 39) in the ONL or photoreceptor outer segments
(Supplementary Figure 3I, L, O and R), although there
was co-expression of PNA in the IPL, a region in the
mouse retina known to express PNA but not cone
photoreceptors (40). Hence, TrkB is expressed in the
RGC and amacrine cell populations of the adult retina
localized to the GCL, IPL and INL.
DLX2-expressing cells co-express TrkB in thedeveloping
and adult murineretina
Previously, expression of DLX2 was demonstrated by
E12.5 in the murine retina (15). In this study, DLX2
Figure 1. Characterization of TrkB protein expression in the developing murine retina. (A) Immunohistochemical localization of TrkB protein in
E12.5 retina. Only a few cells express TrkB in the central inner retina; the GCL originates from this region (A, box; insert, arrows). Immunostaining
of the retinal pigment epithelium along the ophthalmic ventricle and at other epithelial surfaces (presumptive cornea, within the lens ventricle) is non-
speciﬁc. (B–D) Expression of TrkB becomes restricted to the inner retina from E13.5 to E18.5. By E16.5 TrkB expression is localized to a clearly
deﬁned GCL (C). (E) TrkB is localized to the GCL at P14 (E, arrows). (F) TrkB expression is ultimately restricted to RGCs in the adult retina
(F, arrows) as well as in isolated amacrine cells (F, asterisk). Scale bars: (A) 125mM; (B) 500mM; (C, D) 100 mM; (E, F) 50mM. Insert in
(A) represents a 3.5-fold enlargement. GCL, ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; L, lens; NBL, neuroblastic
layer; ONL, outer nuclear layer.
876 Nucleic Acids Research, 2008, Vol. 36, No. 3immunostaining was ﬁrst detected in the dorsal retinal
neuroepithelium by E11.5, where early RGC begin to
diﬀerentiate (Figure 2B). DLX2-expressing cells are found
in both dorsal and ventral retina by E12.5 (Figure 2E)
with only rare TrkB co-expression (Figure 2F); however,
those cells co-expressing TrkB can be readily identiﬁed by
E13.5 (Figure 2I). In the E13.5 presumptive GCL, the
proportion of cells expressing DLX2 is 41.5%, TrkB is
18.2% and those cells co-expressing DLX2 and TrkB is
8.7%. DLX2/TrkB double-positive cells are found in the
inner retina at this stage with DLX2 single-positive cells
located in the outer retina. These DLX2 single-positive
cells primarily identify later born neurons migrating to the
inner retina. By E16.5, the majority of DLX2 expressing
neurons are located in the inner retina in the newly
established GCL (Figure 2K). There is now extensive
co-expression with TrkB among the DLX2 positive cells
(Figure 2L). TrkB single-positive cells can be identiﬁed in
the GCL (Figure 2L, arrows) at this stage as well as DLX2
single-positive cells migrating from the outer retina to the
inner retina (Figure 2L, asterisk). By E18.5 DLX2/TrkB
co-expressing cells are predominant throughout the GCL
(Figure 2O). TrkB single-positive cells can still be
identiﬁed but now constitute a minority of the TrkB
population in the GCL (Figure 2O, arrows). DLX2 single-
positive cells are also evident in the inner neuroblastic
layer (NBL) as the INL begins to be established
(Figure 2O, asterisks). In the adult retina, co-expression
of DLX2 and TrkB is found amongst RGCs in the GCL
as well as in the INL (Figure 2R, arrows, asterisk). TrkB
single-positive neurons in the GCL and INL (Figure 2R,
plus) are now rare. These results demonstrate that
the onset of DLX2 expression precedes TrkB expression
in the embryonic GCL by 1–2 days. The onset of TrkB
expression amongst DLX2-expressing neurons appears
upon their migration to the inner retina. This ﬁnding
supports DLX2’s potential role as a transcriptional
regulator of TrkB expression in this RGC population.
DLX2 binds to aregion ofthe TrkB proximal
promoter in vivo
The mouse TrkB gene spans  328kb and contains 17
introns and 18 exons. In order to determine whether
DLX2 directly binds to genomic DNA sequences within
the TrkB gene locus we selected candidate-binding regions
based upon groups of putative TAAT/ATTA home-
odomain DNA binding motifs: one region (termed
R1-pro) was located at nucleotides 57, 445, 126–57, 445,
399 (chromosomal numbering) (Figure 3A and B). R1-pro
is located in the TrkB proximal promoter 842bp 50 of exon
1 and contains three TAAT/ATTA motifs; the latter two
overlap. ChIP was performed on E16.5 retinal tissue and
also E16.5 hindbrain tissue (which does not express Dlx
genes) was used as a negative control. Oligonucleotide
primers encompassing R1-pro were designed (Figure 3B,
italics) and PCR analysis was performed. Mouse genomic
DNA was utilized as a positive control for the PCR
reaction. DLX2 bound to R1-pro in the E16.5 retina
in vivo (Figure 3C). R1-pro could not be identiﬁed by
ChIP in E16.5 hindbrain, nor could this region be
Figure 2. Co-localization of TrkB with DLX2 in the murine retina.
(A–C) DLX2 is ﬁrst expressed in the dorsal retinal neuroepithelium at
E11.5 (B), whereas TrkB is not yet expressed in the retina at this
embryonic stage (A). (D–F) At E12.5, there is onset of TrkB expression
(D), but minimal co-expression with DLX2 whose domain of
expression is extended to the ventral retina (F). (G–I) TrkB is
co-expressed with DLX2 in cells of the central inner retina at E13.5.
DLX2-positive TrkB-negative cells are located in the outer retina (I).
(J–L) TrkB is co-expressed with DLX2 in cells of the inner retina
within the GCL at E16.5 (L). TrkB and DLX2 single-positive cells may
still be identiﬁed at this stage (L, arrows, asterisks). (M–O) TrkB is
co-expressed with DLX2 in the GCL at E18.5 (O). Single-positive TrkB
expressing cells within the GCL are present (O, arrows) as are DLX2
single positives within the inner NBL (O, asterisks). (P–R) TrkB
is co-expressed with DLX2 in cells of GCL (R, arrows) and INL
(R, asterisk) in the adult retina (R). A TrkB single-positive cell within
the INL is evident within this photomicrograph (R, plus). Scale bars:
(C) 100mM; (L, O, R) 50mM.
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antibody (Figure 3C). Oligonucleotide primers were also
generated to ﬂank six other candidate homeodomain-
binding regions within the TrkB proximal promoter other
than R1-pro. DLX2 binding was not detected using these
primers, demonstrating in vivo DLX2-binding speciﬁcity
at R1-pro (Supplementary Figure 4).
EMSA was used to provide in vitro evidence of DLX2
binding speciﬁcity to R1-pro regulatory elements.
Recombinant DLX2 protein binds to R1-pro resulting in
characteristicgelshifts(Figure4A,lane2).Incubationwith
aspeciﬁc DLX2 antibody resulted in a‘supershift’ of bands
for R1-pro (Figure 4A, lane 4). The presence of more than
one band in the ‘supershift’ experiments may be the result
of protein (recombinant or antibody) degradation and/or
possible homodimerization of recombinant DLX2 pro-
teins; this result is similar to those obtained using speciﬁc
DLX antibodies and recombinant DLX proteins when
characterizing regions of the Dlx5/6 intergenic enhancer
(25) or the Neuropilin-2 promoter (41) as candidate Dlx
transcriptional targets. A control antibody did not produce
a supershift for this region, although a non-speciﬁc band
was seen (Figure 4A, lane 5). Hence, DLX2 speciﬁcally
binds to the R1-pro region of the TrkB gene in vitro.
Furthermore, incubation of E13.5 retina nuclear extracts
with radiolabeled oligonucleotide probes containing either
candidate homeodomain-binding region (Figure 4, TrkB
motif 1, B lanes 1–5; TrkB motif 2, B lanes 6–10) also
demonstrated speciﬁc gel shifts, thereby conﬁrming bind-
ing of endogenous DLX2 to the TrkB proximal promoter
in vitro (Figure 4B, lanes 2 and 7); these gel shifts were not
visualized when retinal nuclear extracts were incubated
with unlabeled probes (Figure 4B, lanes 3 and 8) or labeled
probes containing mutant homeodomain-binding motifs
(Supplementary Figure 5, lanes 6 and 12). Similarly,
incubation with a speciﬁc but not a control antibody
resulted in supershifted bands (Figure 4B, lanes 5 and 10).
Incubation of nuclear extracts obtained from embryonic
liver, tissue that does not express DLX2, did not show
speciﬁc gel shifts or supershifts (Supplementary Figure 5).
These experiments support the speciﬁcity of DLX2 binding
to regions of the TrkB proximal promoter identiﬁed by
chromatin immunoprecipitation in situ and that either
regulatory binding domain within the R1-pro region is
required for binding to endogenous DLX2.
DLX2 activates TrkB promoter and enhancer
elements in vitro
In order to demonstrate the functional signiﬁcance of
DLX2 binding to the TrkB proximal promoter, luciferase
reporter gene assays were performed. Dlx2 co-transfection
Figure 4. DLX2 binds to TrkB proximal promoter elements isolated by
chromatin IP. (A) EMSA were performed using recombinant DLX2
protein and radiolabeled R1-pro oligonucleotide probes, with cold
competition using unlabeled probe (A, lane 3) and speciﬁc DLX2
antibody ‘supershift’ assays (A, lane 4). Lane 1: labeled R1-pro alone.
Lanes 2–5: labeled R1-pro probes were incubated with rDLX2 (2),
rDLX2 and unlabeled R1-pro (3), rDLX2 and anti-DLX2 (4) and
rDLX2 and a control antibody (5). (B) EMSA was also done using
embryonic retinal nuclear extracts and radiolabeled R1-pro oligonu-
cleotide probes containing either the ﬁrst (TrkB motif 1, lanes 1–5) or
second (TrkB motif 2, lanes 6–10) candidate homeodomain binding
sites, with cold competition using unlabeled probe (B, lanes 3 and 8)
and speciﬁc DLX2 antibody ‘supershift’ assays (B, lanes 5 and 10).
Lanes 1, 6: labeled R1-pro alone. Lanes 2–10: labeled R1-pro probes
were incubated with nuclear extract (2,7), nuclear extract and unlabeled
TrkB motifs (3,8), nuclear extract and a control antibody (4,9) or
nuclear extract and anti-DLX2 (5,10).
Figure 3. Genomic organization of the mouse TrkB gene, location of
candidate homeoprotein binding sites, and conﬁrmation that DLX2
binds to the TrkB proximal promoter in embryonic retina in vivo.
(A) TrkB is located on murine chromosome 13 and contains 18 exons
and 17 introns. Putative DLX2-binding regions are located within the
50 proximal promoter region (R1-pro). (B) Sequence and organization
of candidate homeodomain DNA-binding motifs in the TrkB gene.
Candidate TAAT/ATTA homeodomain-binding motifs are underlined.
PCR oligonucleotide primer sites are in italics and boxed. (C) E16.5
retina was cross-linked and immunoprecipitated with speciﬁc DLX2
antibodies following a modiﬁed chromatin immunoprecipitation (ChIP)
protocol. After isolation of genomic DNA fragments bound to DLX2
homeoprotein, PCR using oligonucleotide primers to the proximal
promoter (R1-pro) of the TrkB gene was performed. Total genomic
DNA was used as a positive control. PCR products were subcloned
and sequence-veriﬁed. E16.5 hindbrain was utilized as a tissue-negative
control for ChIP assays.
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expression (Figure 5). Observed normalized increases were
 2-fold for the R1-pro (P<0.05). Using site-directed
mutagenesis (25), mutation of either candidate TAAT/
ATTA DNA-binding motif in the R1-pro region
(Figure 3B) was accomplished. Dlx2 co-transfection with
these mutant TrkB R1-pro constructs (TrkB-m1, TrkB-
m2) did not result in activation of reporter gene expression
(Figure 5). These results support a functional role for
DLX2 as a transcriptional activator of TrkB expression via
binding at these regulatory sites.
Loss offunction ofDlx1/Dlx2 results in decreased
expression of TrkB in thedeveloping murineretina
To determine whether loss of Dlx function aﬀects TrkB
expression in vivo, the Dlx1/Dlx2 double mutant retina
was studied. Mutant and wild-type retinas at E13.5, E16.5
and E18.5 were characterized with regards to TrkB
protein expression. At E13.5, expression of TrkB was
relatively unaﬀected in Dlx1/Dlx2 mutant retinas com-
pared with wild-type littermates (Figure 6B and E).
Quantitative analysis identiﬁed a trend towards fewer
TrkB expressing cells in the Dlx1/Dlx2 mutants
(Figure 6A), although the diﬀerences in TrkB+ cells did
not reach statistical signiﬁcance (T=2.78, P=0.05,
N=5). However, by E16.5, there were markedly fewer
TrkB expressing cells in the mutant retinas (Figure 6C and
F) with a signiﬁcant 43% reduction (T=9.53, P<0.05,
N=5) (Figure 6A, asterisk). The reduction in TrkB-
expressing cells was still evident at E18.5 (Figure 6D and
G). At this stage there was a 30% reduction (T=10.43,
P<0.05, N=5) (Figure 6A, plus). Hence, TrkB expres-
sion is signiﬁcantly reduced in the Dlx1/Dlx2 double
knockout retina at E16.5 and E18.5.
Gain of Dlx2 function in retinal explant cultures
results in increased TrkB expression and increased
expression of RGC and amacrine cell markers
Retroviral transduction of E18.5 retinal explant
cultures with pMXIE-EGFP or pMXIE-EGFP/dlx2 was
performed in order to determine whether gain of Dlx2
function is suﬃcient to alter expression of TrkB or markers
of speciﬁc retinal cell classes. Although eﬃciency of
transduction is low (<5%) due to the poor penetration
of exogenously applied retrovirus as well as the relatively
small number of proliferating cells, one can readily identify
and characterize the transduced cells that express GFP.
Explants transduced with pMXIE-EGFP retrovirus
co-localized with TrkB protein in 32% of transduced
cells, as identiﬁed by GFP ﬂuorescence and TrkB IF. There
was a signiﬁcant (T=5.67, P<0.05, N=5) increase in
co-localization with TrkB (to 62%) in cells transduced by
pMXIE-EGFP/dlx2 (Figure 7A, asterisk). Transduction
with pMXIE-EGFP/dlx2 as compared to pMXIE-EGFP
also resulted in signiﬁcant increases in co-localization with
Islet1 (42 versus 23%, T=4.17, P<0.05, N=5), a
marker of RGCs and syntaxin (46 versus 29%, T=6.04,
P<0.05, N=5), a general marker for amacrine cells
(Figure 7A, hash, plus). No signiﬁcant diﬀerences were
Figure 6. TrkB expression in the Dlx1/Dlx2 mutant retina.
(A) Quantiﬁcation of TrkB expressing cells in the Dlx1/Dlx2 mutant.
At E13.5 there is no signiﬁcant diﬀerence between the number of
TrkB-expressing cells in the Dlx1/Dlx2 mutant retina compared with
wild-type controls (T=2.78, P=0.05, N=5). At E16.5 (A, asterisk)
and E18.5 (A, plus) there is a signiﬁcant reduction in the number of
TRKB-positive cells in the neural retina (T=9.53, P<0.05, N=5 for
a 43% reduction at E16.5; T=10.43, P<0.05, N=5 for a 30%
reduction at E18.5). (B–G) Expression of TrkB in the wild-type and
Dlx1/Dlx2 mutant murine retina. By E16.5 diﬀerences in the expression
of TrkB are evident in Dlx1/Dlx2 mutant (F) as compared to wild-type
retinas (C) with fewer TrkB-expressing cells identiﬁable in the GCL.
This diﬀerence is also observed at E18.5 (D, wild-type; G, mutant).
Error bars represent SDs. Scale bars: (A) 100mM; (F, G) 50mM.
Figure 5. Dlx2 transfection activates transcription of TrkB regulatory
element luciferase reporter genes in vitro. In HEK 293 cells, luciferase
gene reporter constructs containing either the wild-type proximal
promoter region of TrkB isolated by chromatin immunoprecipitation
(R1-pro) or mutant candidate homeodomain-binding sites (TrkB-m1 or
TrkB-m2) were co-transfected with expression constructs for Dlx2.
Dlx2 co-transfection activated wild-type but not mutant R1-pro
reporter gene expression. Error bars represent SEM;
 denotes P<0.05.
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bipolar cells or rod photoreceptors (Figure 7A). Since
some of the markers are expressed in more than one cell
type, the percentages of cells transduced with pMXIE-
EGFP/dlx2 co-expressing lineage-speciﬁc markers may
exceed 100%. Transduction of E18.5 retinal explant
cultures with pMXIE-EGFP/dlx1 retrovirus was also
performed. No signiﬁcant diﬀerences could be identiﬁed
in co-localization with TrkB or of retinal cell-type markers
in explants transduced by pMXIE-EGFP/dlx1 compared
to pMXIE-EGFP controls (Supplementary Figure 6 and
data not shown). These results support a speciﬁc function
for DLX2 in the diﬀerentiation of RGCs and amacrine
cells during retinogenesis, in part through the direct
transcriptional activation of TrkB expression in the
developing murine retina.
Knockdown of Dlx2 expression in primary embryonic
retinal cultures results in decreasedTrkB expression
Primary dissociated retinal cell cultures at E18.5 were
transfected with duplex siRNAs targeting Dlx2 coding
sequences (siRNA-1 or siRNA-2) or a scrambled control
siRNA (siRNA-C). Transfection with either siRNA
resulted in almost undetectable Dlx2 levels with a
marked reduction of TrkB expression when compared to
control siRNA transfected as well as untransfected retinal
cells (Figure 8). Decreased TrkB expression in these Dlx2
knockdown experiments in primary embryonic retinal
cells corroborates the signiﬁcant reduction of TrkB
expression observed in Dlx1/Dlx2 double knockout
retina by E16.5 (Figure 6).
DISCUSSION
Post-natal TrkB expression becomes restricted
to retinal ganglion andamacrine cells
TrkB expression in the developing retina has been
characterized in the rat (42–44). Whereas TrkB expression
in the murine retina has primarily focused on post-natal
expression (5), we have demonstrated that TrkB expres-
sion in the murine retina begins at E12.5. Expression in
central retinal neuroepithelial cells was coincidental with
cells migrating from the proliferative region of the outer
retina to the inner retina where diﬀerentiation occurs.
In post-natal retina, expression of TrkB was restricted to
the GCL and INL. Co-expression studies concluded that
Figure 8. Knockdown of Dlx2 expression by siRNA in primary
embryonic retinal cultures. Primary dissociated retinal cell cultures at
E18.5 were transfected with duplex siRNAs targeting Dlx2 coding
sequences (siRNA-1 or siRNA-2) or a scrambled control siRNA
(siRNA-C) and RNA was extracted at 48h. A representative RT-PCR
experiment (of three) is presented to compare levels of expression of
Dlx2 and TrkB among the experimental groups. Expression of
GAPDH demonstrates equivalent loading of samples. Both siRNAs
reduced Dlx2 expression to almost undetectable levels and concomi-
tantly decreased TrkB expression when compared to control siRNA
and untransfected retinal cells. PCR of a Dlx2 containing plasmid was
performed as an additional control.
Figure 7. Retroviral transduction of Dlx2 in embryonic retinal
explants. (A) Quantiﬁcation of co-expression of EGFP and TrkB or
markers for retinal cell class following transduction of retinal explants
with either pMXIE-EGFP or pMXIE-EGFP/dlx2 retrovirus. Markers
for cell classes included: Islet1 for RGCs, syntaxin for amacrine cells,
Prox1 for horizontal cells, Chx10 for bipolar interneurons and Rho4D2
for rod photoreceptors. Statistically signiﬁcant diﬀerences could be
identiﬁed between pMXIE-EGFP and pMXIE-EGFP/dlx2-transduced
explants for TrkB (A, asterisk), Islet1 (A, hash) and syntaxin (A, plus).
(B–G) Co-expression of EGFP and TrkB in pMXIE-EGFP or pMXIE-
EGFP/dlx2-transduced explant cultures. (H–J) Expression of EGFP
alone in control, pMXIE-EGFP, pMXIE-EGFP/dlx2-transduced
explants. (K–M) Co-expression of EGFP and DLX2 in pMXIE-
EGFP/dlx2-transduced explants. Error bars represent SDs. Scale bars:
(G–J) 100mM.
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in amacrine cells, but only in the mature retina. While
TrkB expression within adult murine RGCs has been well-
documented (5,22), its expression in amacrine cells in the
mouse has not been previously described, although this
data supports earlier reports of TrkB expression in rat
amacrine cells (42,43).
TrkB expression by E12.5 is signiﬁcant as it demon-
strates a much earlier onset of expression than previously
reported. Initial RGC genesis begins at E10 with extensive
RGC genesis occurring 2 days later (4,45). Our results
suggest that TrkB expression occurs in these cells shortly
after acquisition of RGC identity and TrkB may play a
role in survival of RGCs during early retinogenesis.
Nearly 50% of RGCs die during development (7) in two
distinct phases (5). Previous studies have implicated TrkB
in the regulation of the RGC death rate during the second
post-natal phase when RGC projections form connections
within the SC via target-derived BDNF signaling through
TrkB in the early post-natal period (21). The ﬁrst phase of
RGC death occurs pre-natally with a peak at approxi-
mately E15 (6). This early phase of cell death may be
mediated by signaling through the p75 receptor (6). Our
results demonstrating early TrkB expression suggest that
TrkB may also be involved in the regulation of RGC
death during this ﬁrst phase. The TrkB ligand BDNF is
expressed in the murine retina as early as E10.5 (46)
providing further evidence for TrkB signaling facilitating
pre-natal RGC survival.
DLX2 directly binds and activates transcription
of aTrkB regulatory element
In this study, we have demonstrated that the onset of
DLX2 expression begins in the dorsal retina at E11.5,
earlier than previously reported (15). DLX2 expression is
maintained throughout retinogenesis with expression
restricted to RGCs, amacrine cells and horizontal cells
in the murine retina (15,16). We have demonstrated that
DLX2 expression precedes the expression of TrkB by 1–2
days in the GCL and that DLX2-expressing neurons
co-express TrkB in RGCs and amacrine cells. At E13.5,
co-expression is limited to those DLX2-positive cells
that have migrated to the nascent GCL. However,
migrating DLX2+ neurons remain largely TrkB negative
(Figure 2I). By E16.5 and E18.5 when migration is
complete for most DLX2-positive cells, TrkB is
co-expressed in nearly all observed DLX2+ cells in the
GCL. The same pattern of DLX2 expression preceding
TrkB expression was observed among amacrine cells in the
GCL and INL. The spatio-temporal pattern of DLX2 and
TrkB expression suggests the possibility that DLX2 may
play a role in the transcriptional regulation of TrkB.
Little is known about the transcriptional regulation of
TrkB. Thyroid hormone down-regulates TrkB expression
in the rat brain through a novel response element (47).
Retinoic acid treatment of SH-SY5Y human neuroblas-
toma cells induces a neuronal diﬀerentiation process
featuring increased TrkB expression (48). Recent studies
have demonstrated that the bHLH proteins E47 and
NeuroD directly bind to E-boxes within the proximal
TrkB promoter activating TrkB expression in SH-SY5Y
cells (49). Moreover, the Wilm’s tumor transcription
factor Wt1 activates TrkB by binding a Wt1 consensus
motif in the human NTRK2 promoter. This regulation is
necessary for the expression of TrkB in the epicardium
and intramyocardial blood vessels (50). Herein, utilizing
chromatin immunoprecipitation of embryonic retinal
tissues, we have demonstrated that DLX2 directly binds
to speciﬁc homeodomain-binding motifs within the TrkB
promoter (termed R1-pro) in vivo. Speciﬁcity of DLX2
protein–TrkB promoter DNA interactions was conﬁrmed
by EMSA in vitro using recombinant DLX2 and nuclear
extracts expressing endogenous DLX2 obtained from
embryonic retina. Mutation of either candidate home-
odomain DNA-binding region resulted in loss of speciﬁc
gel shifts. Reporter gene assays demonstrated that DLX2
binding to R1-pro was functionally signiﬁcant as there
was transcriptional activation of this response elements
and this activation was abrogated by mutating either
TAAT/ATTA DNA-binding motif in vitro.
The temporal relationship of DLX2 and TrkB expres-
sion in subpopulations of RGCs, identiﬁcation of DLX2
protein–TrkB DNA sequence complexes in embryonic
retina in vivo, together with the transcriptional activation
of these TrkB gene regulatory elements in vitro suggest
that DLX2 may act to regulate TrkB gene expression in
these RGCs to maintain their survival. These results
demonstrate for the ﬁrst time the regulation of TrkB gene
expression by a homeodomain transcription factor. This
study establishes a direct transcriptional relationship
between a homeodomain protein involved in the diﬀer-
entiation of RGCs (17) and a neurotrophin receptor
implicated in RGC survival (22).
Lossor gainof DLX2 function alters expression of
TrkB inthe developing retina
Dlx1/Dlx2 double mutant mice have increased embryonic
retinal apoptosis resulting in a speciﬁc loss of approxi-
mately one-third of RGCs by E18.5 (17). We have
demonstrated decreased TrkB expression in the Dlx1/
Dlx2 double knockout mouse. Importantly, a signiﬁcant
reduction of TrkB-expressing cells can be identiﬁed by
E16.5 with this loss detected as early as E13.5. Thus, loss
of TrkB expression precedes reduction of RGC numbers
between E16.5 and E18.5 in the Dlx1/Dlx2 double mutant.
Establishing this time-line is important; a decreased RGC
population would aﬀect TrkB quantiﬁcation, since TrkB is
primarily expressed in this retinal cell subclass. Reduced
TrkB expression prior to detection of RGC loss in the
Dlx1/Dlx2 mutant retina suggests a mechanism that may
contribute to the increased RGC apoptosis. Moreover,
acute knockdown of Dlx2 expression in wild-type primary
dissociated embryonic retinal cultures, also results in
decreased TrkB expression. Rodent RGCs appear to be
very sensitive to RNAi, with adult RGC in culture also
showing eﬃcient knockdown (51). These Dlx2 knockdown
experiments support our observations of signiﬁcant
reduction of retinal TrkB expression with the loss of
both Dlx1 and Dlx2 function. Other transcription factors
besides Dlx1/Dlx2 are likely required for the expression of
Nucleic Acids Research,2008, Vol. 36,No. 3 881TrkB, since a large proportion of TrkB-expressing cells
remain in the Dlx1/Dlx2 mutant retina. These unidentiﬁed
genes are probably genetically upstream of Dlx1/Dlx2 or
in parallel pathways. Recently, the basic HLH gene Mash1
has been shown to bind to a region of the Dlx1/Dlx2
intergenic enhancer, using ChIP assays of developing
forebrain (52). However, regulation of Dlx expression by
Mash1 in embryonic retina has not yet been addressed.
We have shown that ectopic Dlx2 expression driven by
retroviral transduction of retinal explant cultures is
suﬃcient for increased TrkB expression. Forced Dlx2
expression also leads to increased expression of RGC and
amacrine cell markers, although ectopic Dlx2 expression
may have occurred in both RGC as well as non-RGC
progenitor populations. Hence, DLX2 promotes the
diﬀerentiation of retinal progenitor cells toward an RGC
or amacrine cell fate. Although TrkB is expressed in both
RGCs and amacrine cells, it remains unclear whether
RGC survival is facilitated by the TrkB signaling path-
way. In support of this hypothesis, NeuroD, shown to
directly activate TrkB expression (49) is suﬃcient to drive
amacrine cell genesis, although it is not required for
amacrine cell development (53).
Somewhat unexpected was our observation that forced
expression of Dlx1 by retroviral transduction did not alter
expression of TrkB or any retinal cell class marker. The
Dlx1/Dlx2 double mutant demonstrates the requirement
for both Dlx1 and Dlx2 function for correct CNS
development (13,54). In the retina, Dlx1 is expressed by
E12.5 but its expression is downregulated at or just prior
to birth, dependent on the mouse strain (16,17). DLX2,
but not DLX1, binds to the Dlx5/Dlx6 intergenic
enhancer in neonatal forebrain and retina in vivo and
only Dlx2 activates expression of this enhancer element
in vitro (25). We have primarily addressed Dlx2 function in
this manuscript due to the availability of speciﬁc
polyclonal antibodies to study DLX2 expression and
perform immunoprecipitation and ‘supershift’ gel shift
assays. Of interest, DLX2 may be a more ‘active’
transcriptional activator (25) or repressor (41) than
DLX1. In co-transfection experiments, Dlx1 and Dlx2
are not synergistic (25,41). Although our results support a
limited requirement for Dlx1 in retinal neurogenesis, loss
of Dlx1 function may also have a contribution to the
retinal phenotype of the Dlx1/Dlx2 double knockouts.
TrkB signaling has been demonstrated to inhibit the
death of immature RGCs (21,22). Mice with null
mutations of TrkB (22) have increased rates of RGC
death during development. Similar increased developmen-
tal cell death within the Dlx1/Dlx2 double mutant retina is
also observed (17). Interestingly, loss of function of TrkB
or BDNF does not aﬀect the ﬁnal number of RGCs
(5,22,55). Therefore, independent mechanisms are pro-
posed for the regulation of ﬁnal RGC numbers. Within
the Dlx1/Dlx2 double mutant mouse there is a marked
loss of cells expressing RGC markers. Dlx1/Dlx2 knock-
out mice die shortly after birth (23). Consequently, the
RGC phenotype of the mature retina of these mutants
remains unknown. Studies of forebrain neurogenesis in
Dlx1/Dlx2 double mutants have demonstrated defects in
interneuron diﬀerentiation and migration (13,41,54,56).
Hence, loss of Dlx function likely results in a more severe
retinal phenotype than that displayed by TrkB mutation
alone. The identiﬁcation of other Dlx transcriptional
targets in the retina may provide further insights into the
role of Dlx genes during retinal cell diﬀerentiation and
survival.
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